Cargando…

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

BACKGROUND: Sleep impairment has been commonly reported in Alzheimer’s disease (AD) patients. The association between sleep dysregulation and AD biomarkers has been separately explored in mild cognitive impairment (MCI) and AD patients. OBJECTIVE: The present study investigated cerebrospinal-fluid (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandes, Mariana, Chiaravalloti, Agostino, Nuccetelli, Marzia, Placidi, Fabio, Izzi, Francesca, Camedda, Riccardo, Bernardini, Sergio, Sancesario, Giuseppe, Schillaci, Orazio, Mercuri, Nicola Biagio, Liguori, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473116/ https://www.ncbi.nlm.nih.gov/pubmed/37662614 http://dx.doi.org/10.3233/ADR-220111

Ejemplares similares

(18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
por: Fernandes, Mariana, et al.
Publicado: (2022)

Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/(18)F-FDG-PET Study
por: Bonomi, Chiara Giuseppina, et al.
Publicado: (2023)

Functional Correlates of Striatal Dopamine Transporter Cerebrospinal Fluid Levels in Alzheimer’s Disease: A Preliminary (18)F-FDG PET/CT Study
por: Camedda, Riccardo, et al.
Publicado: (2023)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective
por: Ricci, Maria, et al.
Publicado: (2021)

Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and (18)F-FDG PET Study
por: Chiaravalloti, Agostino, et al.
Publicado: (2016)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Evaluation of Task-Related Brain Activity: Is There a Role for (18)F FDG-PET Imaging?
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An (18)F-FDG PET/CT study
por: CHIARAVALLOTI, AGOSTINO, et al.
Publicado: (2015)

A Rare Case of Primary Uterine Non-Hodgkins's Lymphoma with Involvement of Right Ovary: Staging with 18F FDG PET/CT and Iodinated Contrast CT
por: Lamacchia, Feliciana, et al.
Publicado: (2019)

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline
por: Liguori, Claudio, et al.
Publicado: (2017)

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study
por: Chiaravalloti, Agostino, et al.
Publicado: (2017)

Initial Staging of Hodgkin’s Disease: Role of Contrast-Enhanced (18)F FDG PET/CT
por: Chiaravalloti, Agostino, et al.
Publicado: (2014)

Cortical Metabolic Arrangement During Olfactory Processing: Proposal for a (18)F FDG PET/CT Methodological Approach
por: Micarelli, Alessandro, et al.
Publicado: (2014)

Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center
por: Vacca, Mariacarolina, et al.
Publicado: (2021)

Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder
por: Mattioli, Pietro, et al.
Publicado: (2022)

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
por: Liguori, Claudio, et al.
Publicado: (2018)

The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer’s Disease: A Special Focus on Cognitive Performance
por: Fernandes, Mariana, et al.
Publicado: (2021)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy
por: Calvello, Carmen, et al.
Publicado: (2023)

The Sleepiness–Depression Link in Obstructive Sleep Apnea: Preliminary Results on the Mediation of Impulsivity
por: Vacca, Mariacarolina, et al.
Publicado: (2023)

Is cerebral glucose metabolism related to blood–brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A (18)F-FDG PET/CT study
por: Chiaravalloti, Agostino, et al.
Publicado: (2016)

Prognostic Value of (18)F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
por: Filippi, Luca, et al.
Publicado: (2020)

Subependymal Spread of Glioblastoma Multiforme in Positron Emission Tomography/Computed Tomography
por: Chiaravalloti, Agostino, et al.
Publicado: (2017)

18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2021)

The Brain Metabolic Correlates of the Main Indices of Neuropsychological Assessment in Alzheimer’s Disease †
por: Chiaravalloti, Agostino, et al.
Publicado: (2020)

Detection Rate and Clinical Impact of PET/CT with (18)F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study
por: Filippi, Luca, et al.
Publicado: (2022)

Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
por: Toniolo, Sofia, et al.
Publicado: (2023)

A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
por: Daniela, Perani, et al.
Publicado: (2014)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019)

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
por: Cariulo, Cristina, et al.
Publicado: (2019)

The Role and Potential of (18)F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics
por: Filippi, Luca, et al.
Publicado: (2022)

Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid
por: Liguori, Claudio, et al.
Publicado: (2019)

PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score
por: Dondi, Francesco, et al.
Publicado: (2023)

Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”
por: Perani, Daniela, et al.
Publicado: (2014)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
por: Romigi, A., et al.
Publicado: (2014)

Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy?
por: Mari, Luisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ottkn9bf442ta0co9dfnu9bv9